Search

everythinglearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

COVID-19 infection may trigger alopecia areata in some patients.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Somatostatin may help protect hair follicles from immune attacks.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Apremilast did not work for treating severe alopecia areata.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

ILC1-like cells can independently cause alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Plucked hair follicles can help diagnose scalp lupus.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.